Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade. 

Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade.&nbsp;

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma. 

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

Eureka!

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.

McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&amp;D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.